Skip to Main Content

Knowledge Center


Mortality and Morbidity of COVID-19 Survivors

Mortality and morbidity trends among hospitalized COVID-19 survivors can shed vital light into the insurance implications of the pandemic. 

RGA's Dr. John Lefebre reviews recent research, exploring factors that may influence the relative mortality risk of hospitalized patients versus matched control groups, including older age, preexisting comorbidities, and socioeconomic status.

Dr. Lefebre also investigates factors that may contribute to long COVID or post-COVID syndrome among survivors, including the role of undiagnosed medical conditions and preexisting comorbidities in increasing the risk of both long COVID and related symptoms among hospitalized survivors. He explores differences between the general and insured populations in incidence and prevalence, and also explores the potential benefits of vaccination in reducing risk in morbidity among survivors.

See also: Coverage over the Long-Haul: Managing Disability Claims for long COVID

At RGA, we are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to discuss and learn more about the RGA capabilities, resources, and solutions.  

The Presenter

  • Dr. John J. Lefebre

    Vice President,
    Senior Global Technical Medical Director
    Global Medical


Curious about RGA's medical insights?  Contact us to learn more. 

This video was developed in conjunction with actuview, the first permanent international media platform for actuaries ( actuview content reflects contributions from actuarial institutions, corporate partners and industry professionals. RGA is actuview’s sponsoring partner.
  • cancer
  • coronavirus life insurance
  • covid prevention
  • covid therapeutic
  • covid treatment
  • covid vaccine
  • covid vaccines
  • COVID-19 insurance
  • Disease epidemiology
  • epidemic life insurance
  • Erin Crump
  • experience studies
  • fitness tracker insurance
  • globalization virus life insurance
  • infectious disease life insurance; flu insurance; pneumonia insurance
  • insurance application contestability
  • insurance application regulation exclusion
  • insurance bundle
  • insurance future
  • insurance gap
  • insurance linked wellness program
  • internet of things insurance
  • Iot data insurance
  • IoT insurance
  • Lefebre
  • life-style related mortality
  • long covid
  • long-term effects covid
  • long-term medical effects of covid
  • Mental health insurance
  • MERS
  • morbidity improvement
  • mortality flu life insurance
  • mortality improvement
  • pandemic life insurance
  • pandemic risk
  • return to work covid
  • ripple effects
  • SARS
  • SARS-CoV-2 morbidity
  • SARS-CoV-2 mortality
  • social determinants of mortality
  • social determinants of mortality and morbidity
  • underwriting governance
  • urbanization risk
  • virus life insurance